Lars Christian Petersen
Biopharmaceuticals Research Unit
Novo Nordisk A/S
Måløv
Denmark
Name/email consistency: high
- Intravascular inhibition of factor VIIa and the analogue NN1731 by antithrombin. Petersen, L.C., Karpf, D.M., Agersø, H., Hermit, M.B., Pelzer, H., Persson, E., Nichols, T.C., Ezban, M. Br. J. Haematol. (2011)
- Plasma elimination kinetics for factor VII are independent of its activation to factor VIIa and complex formation with plasma inhibitors. Petersen, L.C., Elm, T., Ezban, M., Krogh, T.N., Karpf, D.M., Steinø, A., Olsen, E.H., Sørensen, B.B. Thromb. Haemost. (2009)
- Microarray studies of factor VIIa-activated cancer cells. Petersen, L.C. Thromb. Res. (2008)
- Characterization of recombinant murine factor VIIa and recombinant murine tissue factor: a human-murine species compatibility study. Petersen, L.C., Nørby, P.L., Branner, S., Sørensen, B.B., Elm, T., Stennicke, H.R., Persson, E., Bjørn, S.E. Thromb. Res. (2005)